Member Info for Reprobus

As per the usual monthly trend, i'm assuming that we'll receive an RNS next week with it being the last week of the month.

Is it going to be IPO news?
Is it going to be an SGS update?
Is it going to be news of another investment?

We can only speculate

Good luck all

Personally Peak, i believe it's always best to top slice "some" profits when the opportunity arrives. I'd never risk being fully out of an investment which i believe in. My ?goal is to achieve a decent holding at a low average on all of my investments, be it stocks or crypto currencies.

Nobody can predict if/when the stock market is going to have another dump, but when it eventually does come around it'll be nice to already be 100% up on your investment, so if there is a 50% market "correction" then you'll still be cutting even (with cash on side to buy more)

Good luck all

Well done HH, i'm very impressed with that holding

At this rate we'll be getting a TR1 notification haha

4x 10m buys just bobbed through

GLA

https://www.bbc.co.uk/news/av/uk-56822930

It’s also worth baring in mind that SGS had hit 144 patients a little while ago, so I’m assuming most of the data has already been collated

The data from the additional 11 patients will hopefully be processed much faster, in tern I’m expecting the initial results by the 2nd week of June at latest. And I would have thought JN is in the process of writing an RNS to confirm that the trial is completed and the next stage is underway

Nice find Andy!

Would love for my 2.1p buy order to be filled before the next round of news

In fairness i think anything under 3p is fair value and will be nothing but a distant memory in a few months time

Agreed.

An £20m Mcap will mean a share price of 0.32p, which could comfortably be achieved this week

Exactly, fundamentals haven't changed.

Looking at the chart, the last time we visited this SP we were oversold (as we are right now) and it took less than 1 week to double in value. Now i'm not expecting us to his 0.5p overnight but i do expect a nice bounce back to 0.35p+ very soon

As mentioned a week or so ago, the SP isn't actually falling. We've been comfortably trading between 0.075p - 0.085p for a while now

Personally, today's drop of the ask & bid is merely to acquire cheap shares before the RNS lands

This is no time to be selling, as realistically this is the bottom and there's lots of support at 0.075p

Agreed, sentiment is certainly changing. There have been far too many hysterical PI's on this board over the past two weeks, but at least they've brought the price down for me to scoop some up.

Good luck all

My buy showing as a sell of course, blimming LSE algorithm aye

Just managed to pick up another 2.5m @ 0.075p!

Absolute bargain of a price right now and i dont' imagine it'll be this low for too much longer

Good luck all

In my opinion, we'll see a decent rise over the next 3-4 weeks as we now know that the trial has ended, so initial results will be with us within 28 days. I'm expecting an RNS to land sometime this week which should add excitement to the market.

As i mentioned last week tho, Vela would benefit from some decent PR to spread the word of their investment and the potential rewards which will follow.

Anything under 0.3p for this stock is a bargain imo

Doubled my holding today.
Way oversold on charts, hasn’t been in this RSI range since December.

Some great info on this thread chaps, we're clearly onto something decent here.

I think the recent press releases in relation to the SGS trial have spread good awareness about the drug and it's potential, but of course there was no mention of Vela in the articles. We as shareholders could just do with news of Vela's investment within the trial being publicised, which should really get the ball rolling here.

I'll take to Twitter later on to spread some awareness.

"The final study visit ('Last Patient Out' date) will be no more than 28 days after completion of enrolment"

Exciting times ahead!

I've just seen some people recommending RMM on the Cobra board, seems like a popular share